“The Drug Industry Thrives on the Revolving Door”

0
338

Sheila Kaplan reports for STAT on a new study finding that more than half of FDA drug reviewers went on to work for the industry. “If you know a major post-employment opportunity is on the other side of the table, you give them the benefit of the doubt,” said Vinay Prasad, senior author on the paper. “You, maybe, make things a little easier on the companies.”

Article →

fda-revolving-door

Support MIA

MIA relies on the support of its readers to exist. Please consider a donation to help us provide news, essays, podcasts and continuing education courses that explore alternatives to the current paradigm of psychiatric care. Your tax-deductible donation will help build a community devoted to creating such change.

$
Select Payment Method
Personal Info

Credit Card Info
This is a secure SSL encrypted payment.

Billing Details

Donation Total: $20 One Time

LEAVE A REPLY